Yahoo News 'I thought I had just pulled a muscle in my back playing golf... what doctors found horrified me'
A dad and granddad was told in his 50s that he could have less than a year to live but says he 'doesn't feel sorry for himself'. Instead, he wants the world to know just one message.
Dad-of-two, Lee Young, 58, was diagnosed with cancer of unknown primary in 2022 and doctors told him that he could have less than a year to live. Cancer of unknown primary is where cancer has spread through the body, but it's not clear where it started.
Prognosis is usually poor because without knowing the location of the original tumour, treatment is limited, and doctors can only give a combination of chemotherapy drugs used to treat a broad range of cancers. But the mechanic from Denton still has hope of finding answers because of incredible research happening in Manchester.
There are around 1,100 deaths from cancer of unknown primary (CUP) every year in the north west, around three every day – making it the sixth most common cause of cancer death in the UK. Lee, who lives with wife Joanne, was diagnosed after experiencing back pain and initially thought he’d pulled a muscle while playing golf. When it didn’t ease, Lee went to see his GP who referred him for tests.
A biopsy revealed an 8.5cm-long tumour near Lee’s kidneys, but to his surprise doctors couldn’t find where the cancer had first started. Then Lee was given the devastating blow that he could have less than a year to live.
He underwent six rounds of chemotherapy as part of a clinical trial and a recent scan discovered that the tumour had reduced in size by half. Now Lee receives immunotherapy every three weeks and continues to be monitored regularly.
Lee said: “I had no idea what cancer of unknown primary was until it was explained to me. After being told the unthinkable I didn’t feel sorry for myself, there are people worse off than me. My glass is always half full, it has to be. The way I feel it’s like I have been given a second chance by outliving the original prognosis and I am grateful and make the most of every day."
The groundbreaking research
But Manchester scientists are working on a groundbreaking new test which aims to unravel the enigma in detecting hidden tumours. Described as a liquid biopsy, the blood test could offer hope for people diagnosed with cancer of unknown primary.
Thanks to a new team set up at the Cancer Research UK National Biomarker Centre in Manchester progress is being made in this area with the discovery of a new blood test that can locate hidden tumours by tracing DNA.
Lee understands more than most the importance of this research. “My tumour has shrunk, but they still can’t find the original source of the cancer, so it’s impossible to treat but they can try to maintain it. This research is vital. If doctors can find out where a cancer starts, then they will know how to treat it, and it could make all the difference to people’s lives," he said.
Now the mechanic from Denton is supporting Stand Up To Cancer – the joint fundraising campaign from Cancer Research UK and Channel 4 - in the hope of finding answers. Scientists have already started work on the test and now they are conducting trials on a larger scale thanks to a funding boost of nearly £400,000 from Stand Up To Cancer.
Co-lead for the project Dr Alexandra Clipson, Deputy Team Leader of the Nucleic Acid Biomarkers Team at the Cancer Research UK National Biomarker Centre said: “We’ve been exploring how we can use something called DNA methylation which is a way that our cells can ‘tag’ DNA. We need to look for a particular combination of these markers which can give us a postcode from a roadmap of the body to pinpoint where that piece of DNA has come from and in turn tell us the primary cancer location. All we need is two teaspoons of blood, so patients don’t need to have an invasive tissue biopsy for this test.
“So far we know our new liquid biopsy test works with high levels of accuracy on a small number of samples, but thanks to this funding from Stand Up To Cancer we’ll be able to test it on a much larger scale to validate the performance of the test to ensure that it is ready to reach patients.”
If successful, it is hoped the test could be rolled out to a clinical trial within three years to help improve treatment options for patients with cancer of unknown primary.
Fellow co-lead Dr Alicia-Marie Conway, Academic Clinical Lecturer at The University of Manchester and CRUK National Biomarker Centre added: “After our research is complete the final stage will be putting the test into a clinical trial of patients with CUP. Then not only will we see if we can make a diagnosis, but we’ll see if treating patients based on the blood tests improves their outcomes and hopefully speed up the time to treatment. This research and this blood test will give patients with CUP hope for the future.”
Lee hopes his story will inspire people to stand together against the disease by raising money to help make the next cancer breakthrough happen.
Lee added: “Cancer can affect anyone’s life, at any time, so we really have no choice other than to unite against it and help support the scientists to keep making new discoveries. That’s why I’m lending my heartfelt support to this vitally important campaign. Now is the time for everyone across Manchester to Stand Up To Cancer. Every action big or small could make a difference.”
Lee is calling on people across Manchester to get involved by taking part in Stand Up To Cancer’s 100 squats a day challenge this November or choosing from a host of fun-filled fundraising ideas with a free pack available online for inspiration and support.
